Overview
Dr. Tendai Kwaramba is a physician-researcher and medical oncologist specializing in gastrointestinal malignancies and global oncology. Her research centers on improving equitable access to cancer prevention, diagnosis, treatment, and survivorship care in resource-limited settings. She leads an ASCO-Conquer Cancer Young Investigator Award–funded study evaluating the implementation of evidence-based treatment de-escalation strategies for early breast cancer in South Africa. Her work bridges health equity, implementation science, and clinical oncology, with a particular focus on optimizing care delivery and resource utilization in low- and middle-income countries.
At Duke Cancer Institute, Dr. Kwaramba is developing research infrastructure that links cancer registry and precision medicine capacity in East Africa. Her broader scholarly portfolio includes work on cancer survivorship risk modeling, early onset cancers, community engagement, disparities in palliative care delivery, and the inclusion of underrepresented populations in cancer research. Drawing on her multidisciplinary background in global health and oncology, Dr. Kwaramba aims to lead collaborative, data-driven initiatives that reduce disparities and advance equitable cancer outcomes worldwide.